NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 530 (2) , 402-409
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81772803, 81972479, 81772643, 81871877, 31501132)
- Science and technology innovation talent support plan of university of Henan province (18HASTIT044)
- Henan Medical Program (201602072)
- Fujian Provincial Department of Science & Technology (2017J01363)
- Health and Family Planning Commission of Fujian Province (2017-ZQN-86)
- Scientific and Technological Planning Project of Guangzhou City (201805010002, 201904010038)
- Natural Science Foundation of Guangdong Province (2019A1515011100)
This publication has 34 references indexed in Scilit:
- Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancerBiochemical and Biophysical Research Communications, 2020
- Ferroptosis: Final destination for cancer?Cell Proliferation, 2020
- Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Cancer Discovery, 2019
- BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cellsBiochemical and Biophysical Research Communications, 2019
- Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cellsCell Death & Disease, 2019
- The molecular machinery of regulated cell deathCell Research, 2019
- Induction of reactive oxygen species: an emerging approach for cancer therapyApoptosis, 2017
- Regulated cell death and adaptive stress responsesCellular and Molecular Life Sciences, 2016
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain InhibitionMolecular Cell, 2014
- BET domain co-regulators in obesity, inflammation and cancerNature Reviews Cancer, 2012